Correlation Between Isofol Medical and Mendus AB

Can any of the company-specific risk be diversified away by investing in both Isofol Medical and Mendus AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Isofol Medical and Mendus AB into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Isofol Medical AB and Mendus AB, you can compare the effects of market volatilities on Isofol Medical and Mendus AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Isofol Medical with a short position of Mendus AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Isofol Medical and Mendus AB.

Diversification Opportunities for Isofol Medical and Mendus AB

0.44

Correlation Coefficient

Isofol Medical  Mendus AB

Very weak diversification

The 3 months correlation between Isofol and Mendus is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Isofol Medical AB and Mendus AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mendus AB and Isofol Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Isofol Medical AB are associated (or correlated) with Mendus AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mendus AB has no effect on the direction of Isofol Medical i.e., Isofol Medical and Mendus AB go up and down completely randomly.

Pair Corralation between Isofol Medical and Mendus AB

Assuming the 90 days trading horizon Isofol Medical AB is expected to generate 1.2 times more return on investment than Mendus AB. However, Isofol Medical is 1.2 times more volatile than Mendus AB. It trades about 0.13 of its potential returns per unit of risk. Mendus AB is currently generating about -0.12 per unit of risk. If you would invest  224.00  in Isofol Medical AB on October 12, 2024 and sell it today you would earn a total of  20.00  from holding Isofol Medical AB or generate 8.93% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Isofol Medical AB  vs.  Mendus AB

Isofol Medical AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Isofol Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Isofol Medical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Mendus AB

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Mendus AB are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Mendus AB is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Isofol Medical and Mendus AB

The main advantage of trading using opposite Isofol Medical and Mendus AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Isofol Medical position performs unexpectedly, Mendus AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mendus AB will offset losses from the drop in Mendus AB's long position.

The idea behind Isofol Medical AB and Mendus AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.